News
Beyond bringing back diseases like measles and TB, defunding NIH will cost the United States its leading role in global ...
Codix Bio GM Olanrewaju Balaja said the company will roll out kits later this month from its plant in partnership with the ...
WHO celebrates FDA's nod to injectable lenacapavir for HIV prevention, promising easier adherence with biannual doses.
3h
Sportschosun on MSN1 in 4 people over 70s chronic kidney disease...COVID-19 Pandemic Level Measures Needed"Now, chronic kidney disease has come at a time when the state needs to take the lead in management like tuberculosis management." Chairman Park Hyung-cheon's remarks were made at the KSN 2025 press ...
JAKARTA: Amid the geographical and social complexities of Papua, new hope emerges through the formation of the Papua Malaria ...
FDA approves Gilead Sciences' groundbreaking HIV prevention injection, Yeztugo, with 99.9% effectiveness, but high cost ...
Patanjali’s study finds ‘Chhoti Kateli’ may help fight tuberculosis and reduce drug resistance, offering hope for safer herbal treatments.
Lancet study underscores fears over potential impact of President Trump’s plan to nearly halve funding in 2025 ...
Codix Bio Ltd, a Nigerian manufacturer, says it plans to produce millions of HIV and malaria test kits at its new plant for ...
Gilead Sciences has received US FDA approval for Yeztugo, its bi-annual HIV prevention injection, which has shown 96 per cent ...
Nigerian health technology company Codix Bio Ltd has announced plans to begin large-scale local production of HIV and malaria ...
A novel, portable assay can deliver TB diagnoses in under an hour at low cost using samples of blood, saliva, or sputum, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results